BIOMARIN PHARMACEUTICAL INC

CUSIP: 09061GAH4 Class: Convertible Debt

WELLS FARGO & COMPANY/MN's Holding History (CIK: 0000072971)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 19,500 Value ($000) $19 Avg Close — Range —
Q1 2024
Shares 5,201,500 Value ($000) $5,120 Avg Close — Range —
Q4 2023
Shares 3,461,500 Value ($000) $3,412 Avg Close — Range —
Q3 2023
Shares 3,701,500 Value ($000) $3,594 Avg Close — Range —
Q2 2023
Shares 3,012,500 Value ($000) $2,971 Avg Close — Range —
Q1 2023
Shares 3,137,500 Value ($000) $3,223 Avg Close — Range —
Q4 2022
Shares 3,159,500 Value ($000) $3,360 Avg Close — Range —
Q3 2022
Shares 3,257,500 Value ($000) $3,243 Avg Close — Range —
Q2 2022
Shares 3,295,500 Value ($000) $3,262 Avg Close — Range —
Q1 2022
Shares 4,231,500 Value ($000) $4,260 Avg Close — Range —
Q4 2021
Shares 2,980,500 Value ($000) $3,117 Avg Close — Range —
Q3 2021
Shares 3,086,500 Value ($000) $3,158 Avg Close — Range —
Q2 2021
Shares 3,054,500 Value ($000) $3,165 Avg Close — Range —
Q1 2021
Shares 3,699,500 Value ($000) $3,743 Avg Close — Range —
Q4 2020
Shares 3,914,500 Value ($000) $4,200 Avg Close — Range —
Q3 2020
Shares 1,999,000 Value ($000) $2,098 Avg Close — Range —
Q2 2020
Shares 2,142,000 Value ($000) $2,618 Avg Close — Range —
Q1 2020
Shares 2,204,000 Value ($000) $2,310 Avg Close — Range —
Q4 2019
Shares 2,376,000 Value ($000) $2,511 Avg Close — Range —
Q3 2019
Shares 2,476,000 Value ($000) $2,434 Avg Close — Range —
Q2 2019
Shares 2,570,000 Value ($000) $2,668 Avg Close — Range —
Q1 2019
Shares 2,694,000 Value ($000) $2,756 Avg Close — Range —
Q4 2018
Shares 3,782,000 Value ($000) $3,761 Avg Close — Range —
Q3 2018
Shares 2,770,000 Value ($000) $2,952 Avg Close — Range —
Q1 2018
Shares 2,365,000 Value ($000) $2,239 Avg Close — Range —
Q4 2017
Shares 5,513,000 Value ($000) $5,520 Avg Close — Range —
Q3 2017
Shares 11,250,000 Value ($000) $11,467 Avg Close — Range —